Cargando…
Management of recurrent pleural mesothelioma: Successful rechallenge with nintedanib in combination with chemotherapy
Malignant pleural mesothelioma (MPM) is a rare neoplasm, generally caused by asbestos exposure. This case details how a patient treated with nintedanib during the LUME‐Meso study was rechallenged with nintedanib. The findings highlight the benefit of nintedanib rechallenge and the potential use of c...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6186873/ https://www.ncbi.nlm.nih.gov/pubmed/30349716 http://dx.doi.org/10.1002/ccr3.1775 |